<DOC>
<DOCNO>
EP-0000207
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
C07B-20060101S C07D-307/935 C07C-401/00 C07D-405/00 A61K-20060101S C07D-307/93 C07C-67/00 C07D-405/12 C07C-51/00 A61K-31/215 C07C-20060101S C07D-307/00 C07C-405/00 A61K-31/20 A61K-31/185 C07D-309/12 C07D-309/00 A61K-31/21 A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
prostaglandin derivatives, their preparation and pharmaceutical compositions and intermediates.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f. hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>
</APPLICANT>
<INVENTOR>
holland george williamus<sep>rosen perryus<sep>holland, george william<sep>rosen, perry<sep>holland, george william10 acorn placenorth caldwell, n.j.us<sep>rosen, perry26 sunset drivenorth caldwell, n.j.us<sep>
</INVENTOR>
<ABSTRACT>
Prostaglandin derivatives of the formula wherein R¹ is hydrogen or lower alkyl; R² hydroxy; R³ hydrogen; or R² and R³ together oxo; R⁴ hydrogen or lower alkyl; R⁵ fluorine, lower alkyl or trifluoromethyl; R⁶ hydrogen, fluorine or lower alkyl; R⁷ hydrogen; R⁸ hydroxy; or R⁷ and R⁸ together Oxo; a and b, and X and Y, for themselves hydrogen or together a carbon carbon bond; with the condition that R² and R³ together represent Oxo when R⁷ and R⁸ are Oxo together; and with the further condition that A and B represent hydrogen when R⁷ is hydrogen; and with the third condition that X and Y represent a carbon carbon bond when R¹ and R⁷ are at the same time hydrogen; Their enantiomers and racemates have therapeutic, z. b. Blood pressure and anti-ulcerogenic effects. The invention relates to such prostaglandin derivatives, the preparation and pharmaceutical preparations containing such prostaglandin derivatives, as well as new intermediates for the preparation of these prostaglandin derivatives.
</ABSTRACT>
</TEXT>
</DOC>
